Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04326946 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

International Alfapump Cohort Study

Study acronym: TOPMOST
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Dec 31, 2023 to Dec 31, 2028
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Dec 31, 2025 to Dec 31, 2030
    • Site details revised at 2 of 2 sites
    v3
  2. Secondary endpoints: details revised at 5 of 14 entriesv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This Registry is designed to follow patients who have been implanted with an alfapump system, which is a newly marketed product from Sequana Medical AG, a Swiss Medical Device company.
Trial Details
NCT Number NCT04326946
Lead Sponsor Sequana Medical N.V.
Conditions
(from sponsor)		 Liver Cirrhoses, Malignant Ascites
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov